Breakthrough treatment: Locanemab is approved to treat early-onset Alzheimer’s disease
According to the Alzheimer’s Drug Discovery Foundation and the article published in the New England Journal of Medicine, the United States Food and Drug Administration (FDA) has approved Loca…
